Nanobiotix S.A. Statistics
Share Statistics
Nanobiotix S.A. has 49.17M shares outstanding. The number of shares has increased by 12.97% in one year.
| Shares Outstanding | 49.17M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 6.9% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 38.88M |
| Failed to Deliver (FTD) Shares | 24.00K |
| FTD / Avg. Volume | 75.39% |
Short Selling Information
The latest short interest is 71.11K, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 71.11K |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | 1.55 |
Valuation Ratios
The PE ratio is -6.15 and the forward PE ratio is -1.6.
| PE Ratio | -6.15 |
| Forward PE | -1.6 |
| PS Ratio | 8.12 |
| Forward PS | 1.9 |
| PB Ratio | -132.44 |
| P/FCF Ratio | -19.05 |
| PEG Ratio | n/a |
Enterprise Valuation
Nanobiotix S.A. has an Enterprise Value (EV) of 218.50M.
| EV / Earnings | -5.5 |
| EV / Sales | 7.27 |
| EV / EBITDA | -7.26 |
| EV / EBIT | -8.16 |
| EV / FCF | -17.05 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of -24.68.
| Current Ratio | 1.75 |
| Quick Ratio | 1.75 |
| Debt / Equity | -24.68 |
| Total Debt / Capitalization | 104.22 |
| Cash Flow / Debt | -0.27 |
| Interest Coverage | -3.35 |
Financial Efficiency
Return on equity (ROE) is 21.54% and return on capital (ROIC) is -55.13%.
| Return on Equity (ROE) | 21.54% |
| Return on Assets (ROA) | -0.42% |
| Return on Capital (ROIC) | -55.13% |
| Revenue Per Employee | 273.25K |
| Profits Per Employee | -360.91K |
| Employee Count | 110 |
| Asset Turnover | 0.32 |
| Inventory Turnover | -30.75 |
Taxes
| Income Tax | 120.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -63.01% in the last 52 weeks. The beta is 1.4, so Nanobiotix S.A.'s price volatility has been higher than the market average.
| Beta | 1.4 |
| 52-Week Price Change | -63.01% |
| 50-Day Moving Average | 3.43 |
| 200-Day Moving Average | 5 |
| Relative Strength Index (RSI) | 37.64 |
| Average Volume (20 Days) | 31.83K |
Income Statement
In the last 12 months, Nanobiotix S.A. had revenue of 30.06M and earned -39.70M in profits. Earnings per share was -1.08.
| Revenue | 30.06M |
| Gross Profit | 30.06M |
| Operating Income | -26.78M |
| Net Income | -39.70M |
| EBITDA | -30.09M |
| EBIT | -26.78M |
| Earnings Per Share (EPS) | -1.08 |
Balance Sheet
The company has 75.28M in cash and 50.56M in debt, giving a net cash position of 24.72M.
| Cash & Cash Equivalents | 75.28M |
| Total Debt | 50.56M |
| Net Cash | 24.72M |
| Retained Earnings | -39.70M |
| Total Assets | 86.68M |
| Working Capital | 23.94M |
Cash Flow
In the last 12 months, operating cash flow was -12.48M and capital expenditures -337.00K, giving a free cash flow of -12.81M.
| Operating Cash Flow | -12.48M |
| Capital Expenditures | -337.00K |
| Free Cash Flow | -12.81M |
| FCF Per Share | -0.35 |
Margins
Gross margin is 120.46%, with operating and profit margins of -89.09% and -132.08%.
| Gross Margin | 120.46% |
| Operating Margin | -89.09% |
| Pretax Margin | -131.68% |
| Profit Margin | -132.08% |
| EBITDA Margin | -100.09% |
| EBIT Margin | -89.09% |
| FCF Margin | -42.63% |
Dividends & Yields
NBTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -37.24% |
| FCF Yield | -8.99% |
Analyst Forecast
The average price target for NBTX is $12, which is 313.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 313.8% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | -4.64 |
| Piotroski F-Score | 4 |